This topic contains definition, meaning, classification, pathophysiology, clinical menifestations, metabolic and general changes, management of obstetrical shock
The increased cardiac output related to pregnancy can lead to heart failure, and the increased heart rate in the third trimester can lead to ischemic events. The potential obstetrical complications include preeclampsia or other hypertensive related disorders, premature birth, and small-for-gestational-age births.
This topic contains definition, meaning, classification, pathophysiology, clinical menifestations, metabolic and general changes, management of obstetrical shock
The increased cardiac output related to pregnancy can lead to heart failure, and the increased heart rate in the third trimester can lead to ischemic events. The potential obstetrical complications include preeclampsia or other hypertensive related disorders, premature birth, and small-for-gestational-age births.
A cyanotic heart defect is a group-type of congenital heart defects (CHDs). The patient appears blue (cyanotic), due to deoxygenated blood bypassing the lungs and entering the systemic circulation. This can be caused by right-to-left or bidirectional shunting, or malposition of the great arteries.
Cyanotic heart defects, which account for approximately 25% of all CHDs, include:
Tetralogy of Fallot (ToF)
Total anomalous pulmonary venous connection
Hypoplastic left heart syndrome (HLHS)
Transposition of the great arteries (d-TGA)
Truncus arteriosus (Persistent)
Tricuspid atresia
Interrupted aortic arch
Pulmonary atresia (PA)
Pulmonary stenosis (critical)
Eisenmenger syndrome(Reversal of Shunt due to Pulmonary Hypertension) .
Patent ductus arteriosus may cause cyanosis in late stage.
INTRODUCTION
DEFINITION
TYPES
CAUSES
MANAGEMENT-Management of 3rd stage bleeding
Actual management
MANAGEMENT OF 3RD STAGE BLEEDING
Steps of management
1. Placental site bleeding-
To palpate the fundus and massage the uterus to make it hard. The massage is to be done by placing four fingers behind the uterus and thumb in front.
To start crystalloid solution (NS or RL) with oxytocin (1L with 20 units) at 60 drops per minute and to arrange for blood transfusion if necessary.
Oxytocin 10 unit IM or methergine 0.2 mg is given intravenously.
To catheterize the bladder.
To give antibiotics (Ampicillin 2gm and Metronidazole 500mg IV)
2. Management of traumatic bleed
The uterovaginal canal is to be explored under general anesthesia after the placenta is expelled and haemostatic sutures are placed on the offending sites.
STEPS OF MANUAL REMOVAL OF PLACENTA
The patient is placed in lithotomy position. With all aseptic measures, the bladder is catheterized.
One hand is introduced into the uterus in cone shaped manner following the cord. While introducing the hand, the labia are separated by the fingers at the other hand.
Counter pressure on the uterine fundus is applied by the hand placed over the abdomens. The abdominal hand should steady the fundus and guide the movement of the fingers inside the uterine cavity till the placenta is completely separated.
Situs Inversus totalis is a genetic condition that causes the organs in the chest and abdomen to be positioned in a mirror image from their normal positions.
This gives an idea about the Signs/Symptom, Diagnosis, Treatment and Special concerns of the syndrome.
A cyanotic heart defect is a group-type of congenital heart defects (CHDs). The patient appears blue (cyanotic), due to deoxygenated blood bypassing the lungs and entering the systemic circulation. This can be caused by right-to-left or bidirectional shunting, or malposition of the great arteries.
Cyanotic heart defects, which account for approximately 25% of all CHDs, include:
Tetralogy of Fallot (ToF)
Total anomalous pulmonary venous connection
Hypoplastic left heart syndrome (HLHS)
Transposition of the great arteries (d-TGA)
Truncus arteriosus (Persistent)
Tricuspid atresia
Interrupted aortic arch
Pulmonary atresia (PA)
Pulmonary stenosis (critical)
Eisenmenger syndrome(Reversal of Shunt due to Pulmonary Hypertension) .
Patent ductus arteriosus may cause cyanosis in late stage.
INTRODUCTION
DEFINITION
TYPES
CAUSES
MANAGEMENT-Management of 3rd stage bleeding
Actual management
MANAGEMENT OF 3RD STAGE BLEEDING
Steps of management
1. Placental site bleeding-
To palpate the fundus and massage the uterus to make it hard. The massage is to be done by placing four fingers behind the uterus and thumb in front.
To start crystalloid solution (NS or RL) with oxytocin (1L with 20 units) at 60 drops per minute and to arrange for blood transfusion if necessary.
Oxytocin 10 unit IM or methergine 0.2 mg is given intravenously.
To catheterize the bladder.
To give antibiotics (Ampicillin 2gm and Metronidazole 500mg IV)
2. Management of traumatic bleed
The uterovaginal canal is to be explored under general anesthesia after the placenta is expelled and haemostatic sutures are placed on the offending sites.
STEPS OF MANUAL REMOVAL OF PLACENTA
The patient is placed in lithotomy position. With all aseptic measures, the bladder is catheterized.
One hand is introduced into the uterus in cone shaped manner following the cord. While introducing the hand, the labia are separated by the fingers at the other hand.
Counter pressure on the uterine fundus is applied by the hand placed over the abdomens. The abdominal hand should steady the fundus and guide the movement of the fingers inside the uterine cavity till the placenta is completely separated.
Situs Inversus totalis is a genetic condition that causes the organs in the chest and abdomen to be positioned in a mirror image from their normal positions.
This gives an idea about the Signs/Symptom, Diagnosis, Treatment and Special concerns of the syndrome.
Hemorrhage is the leading cause of preventable death following trauma. Non-compressible hemorrhage is of particular concern as these patients require emergent intervention and many will die prior to anatomic hemostasis. For years, left anterior thoracotomy, the “ED thoracotomy”, was the standard of care for temporary proximal aortic occlusion, but survival remained dismal. Endoluminal aortic occlusion which was actually first described in the 1950s. With the increasing use of endovascular therapies for a wide variety of vascular disease, the “REBOA” (Resuscitative Endovascular Balloon Occlusion of the Aorta) began to be reported for use for ruptured abdominal aneurysms in the 2000s. Since that time, interest in its use in trauma has been increasing with a variety of basic science studies and early clinical series and case reports documenting potential benefits. Although no large randomized trials, or even large observational studies, are available, use of the REBOA is considered standard of care in many centers. Typically the REBOA is placed via the femoral artery either percutaneously or via a cut down and the aorta is occluded with a balloon placed over a wire by standard Seldinger-type technique. The balloon can be placed in “zone 1” just above the diaphragm to provide occlusion to the abdominal viscera and pelvic vasculature or in “zone 3” at the aortic bifurcation to provide inflow control to the pelvis and lower extremities. Injuries are then addressed and the balloon is carefully deflated taking care to avoid metabolic collapse from reperfusion. One main limitation of this technique is that the currently approved device in the United States requires a 12F sheath which requires an open femoral artery repair which obvious can be associated with significant complications. There are a huge number of unanswered questions about the use of REBOA in 2015:
1. Who are the appropriate patients in whom use may be beneficial?
2. How long can a balloon be inflated and the aorta be occluded before irreversible ischemic damage to the viscera occurs?
3. How long can the aorta be occluded before the metabolic consequences of reperfusion are lethal?
4. What is the effect on cerebral and cardiac perfusion when a REBOA is placed and afterload is acutely increased? Is it favorable or “too much”?
5. Who are the appropriate providers to place a REBOA? Only surgeons? Emergency Medicine physicians? Medics in the field?
6. How do we best train providers to place the REBOA?
7. How to we assure competency of providers?
8. Will lower profile devices make the technique more accessible and be associated with fewer complications?
This gives a brief idea about the:
Techniques, Response To NIV, Clinical indications, Contraindications and Evidence Based Decisions on the use of noninvasive ventilation with neonates
This is an ARDS case study presentation done by a group of Respiratory care students in UOD:
Aziza AlAmri, Fay AlBuainain, Mashail AlRayes, Nora AlWohayeb, Salma Almakinzi .
The original case study:(http://www.researchgate.net/publication/50399037_Acute_Respiratory_Distress_SyndromeA_Case_Study)
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
COVID-19 PCR tests remain a critical component of safe and responsible travel in 2024. They ensure compliance with international travel regulations, help detect and control the spread of new variants, protect vulnerable populations, and provide peace of mind. As we continue to navigate the complexities of global travel during the pandemic, PCR testing stands as a key measure to keep everyone safe and healthy. Whether you are planning a business trip, a family vacation, or an international adventure, incorporating PCR testing into your travel plans is a prudent and necessary step. Visit us at https://www.globaltravelclinics.com/
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...Kumar Satyam
According to the TechSci Research report titled “India Diagnostic Labs Market Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2019-2029,” the India Diagnostic Labs Market was valued at USD 16,471.21 million in 2023 and is projected to grow at an impressive compound annual growth rate (CAGR) of 11.55% through 2029. This significant growth can be attributed to various factors, including collaborations and partnerships among leading companies, the expansion of diagnostic chains, and increasing accessibility to diagnostic services across the country. This comprehensive report delves into the market dynamics, recent trends, drivers, competitive landscape, and benefits of the research report, providing a detailed analysis of the India Diagnostic Labs Market.
Collaborations and Partnerships
Collaborations and partnerships among leading companies play a pivotal role in driving the growth of the India Diagnostic Labs Market. These strategic alliances allow companies to merge their expertise, strengthen their market positions, and offer innovative solutions. By combining resources, companies can enhance their research and development capabilities, expand their product portfolios, and improve their distribution networks. These collaborations also facilitate the sharing of technological advancements and best practices, contributing to the overall growth of the market.
Expansion of Diagnostic Chains
The expansion of diagnostic chains is a driving force behind the growing demand for diagnostic lab services. Diagnostic chains often establish multiple laboratories and diagnostic centers in various cities and regions, including urban and rural areas. This expanded network makes diagnostic services more accessible to a larger portion of the population, addressing healthcare disparities and reaching underserved populations. The presence of diagnostic chain facilities in multiple locations within a city or region provides convenience for patients, reducing travel time and effort. A broader network of labs often leads to reduced waiting times for appointments and sample collection, ensuring that patients receive timely and efficient diagnostic services.
Rising Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases is a significant driver for the demand for diagnostic lab services. Chronic conditions such as diabetes, cardiovascular diseases, and cancer require regular monitoring and diagnostic testing for effective management. The rise in chronic diseases necessitates the use of advanced diagnostic tools and technologies, driving the growth of the diagnostic labs market. Additionally, early diagnosis and timely intervention are crucial for managing chronic diseases, further boosting the demand for diagnostic lab services.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
For those battling kidney disease and exploring treatment options, understanding when to consider a kidney transplant is crucial. This guide aims to provide valuable insights into the circumstances under which a kidney transplant at the renowned Hiranandani Hospital may be the most appropriate course of action. By addressing the key indicators and factors involved, we hope to empower patients and their families to make informed decisions about their kidney care journey.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
2. WHAT ARE THROMBOEMBOLIC DISEASES ?
They are caused when a blood vessel is
obstructed by a blood clot (embolus) that has
been carried in the bloodstream from the site of
its formation.
2
5. OBJECTIVES
• Definition
• Incidence
• Symptoms
• Risk factors and causes
• Clinical presentation
• Complications
• Exams and Tests
• Treatment
• Prevention
• Case study
5
6. WHAT IS PULMONARY EMBOLISM ?
6
In Other Words : PE is the sudden
blockage of a major blood vessel (artery)
in the lung, usually by a blood clot.
7. WHAT HAPPENS ?
If a large blood clot blocks the artery in
the lung, blood flow may be completely
stopped, causing sudden death.
A smaller clot reduces the blood flow and may
cause damage to lung tissue.
if the clot dissolves on its own, it may not
cause any major problems. 7
8. WHERE DOES IT HAPPENS ?
• It can happen anywhere in the lungs
– But since more blood flows into the bases of the lungs
• Pulmonary Embolism is more in the lower parts
– And less in the upper portion
» As a result of gravity
8
9. INCIDENCE
• 600,000 per year get PE In the US
• This results in 50,000-200,000 deaths per year.
Based on the estimates on 2012
9
10. SYMPTOMS
Begins suddenly ..
Sudden shortness of breath.
Sharp chest pain that is worse with cough or deep breath.
A cough that brings up pink, foamy mucus.
Rapid breathing
can also cause more general symptoms such as :
anxiety
sweating a lot
feeling lightheaded
fainting
fast heart rate or palpitations. 10
11. CAUSES
Blood clot in the leg that breaks loose and
travels to the lungs .
Deep vain thrombosis .
Other things can block the artery, such as tumors,
air bubbles, amniotic fluid, or fat that is released
into the blood vessels when a bone is broken. But
these are rare. 11
12. RISK FACTORS
Being inactive for long periods.
Recent surgery that involves the legs, hips, belly, or brain.
Some diseases, such as cancer, heart failure, stroke, or a
severe infection.
Pregnancy and childbirth (cesarean section).
Taking birth control pills or hormone therapy.
Smoking.
Older than 70
Extremely overweight (obese).
12
13. PRESENTATION
13
Most Common
Symptoms
Dyspnea at rest or with
exertion
Pleuritic pain
Cough
>2-pillow orthopnea
Calf or thigh pain
Calf or thigh swelling
Wheezing
Rapid onset of dyspnea
Most Common Signs
Tachypnea
Tachycardia
Rales
Decreased breath
sounds
Jugular venous
distension
14. COMPLICATIONS
Cardiac arrest and sudden death
Shock
Abnormal heart rhythms
Death of part of the lung, called pulmonary
infarction
Pleural effusion
Pulmonary hypertension
14
15. EXAMS AND TESTS
Diagnosing pulmonary embolism is difficult,
because there are many other medical
conditions, such as a heart attack or an anxiety
attack, that can cause similar symptoms.
15
16. EXAMS AND TESTS
1. D-Dimer: is a blood test that measures a
substance that is released when a blood clot
breaks up.
Elevated in thrombosis, malignancy,
pregnancy, elderly, hospitalized patients.
Normal results can rule out PE.
16
18. EXAMS AND TESTS
3.Chest Radiography:
Not a sensitive or specific test for the
diagnosis of PE.
Atelectasis, Pleural effusion, or a pulmonary
parenchymal abnormality is noted most
commonly
Only a small portion of patients with PE have a
normal CXR.
18
23. EXAMS AND TESTS
Pulmonary Angiography:
The “gold standard”
A negative pulmonary angiogram excludes
clinically relevant PE.
The risk of embolization in patients with a
negative angiogram is extremely low
23
24. EXAMS AND TESTS
• More tests can be used , like what ?!
6. MRI
7. ABG “ sudden drop in O2 level”
8. Doppler ultrasound “reflected sound waves to
determine whether a blood clot is present in the
large veins of the legs”
9.Echo “detects abnormalities in the size of right
ventricle”
24
25. AFTER DETERMINATION PE ..
Other tests can help guide treatment and
suggest how well the pt. will recover :
• Brain natriuretic peptide:
A blood test to check the level of the hormone
( level heart under stress )
• protein troponin:
( level damage to the heart’s muscle )
25
26. TREATMENT
Anticoagulant medications
If symptoms are severe and life-threatening, aggressive
treatment is needed
Thrombolytic medications ( risk of sever bleeding )
Remove the clot ( Embolectomy)
26
27. If surgery or medicines are not
options, is there other methods to
prevent pulmonary embolism ?
27
28. YES !
Vena cava filter :
This filter can prevent blood clots in the leg or
pelvic veins from traveling to the lungs and
heart, may be permanent or removable.
31. • A 25 year old white female reports to the
Emergency Room because of sharp left sided
chest pain and shortness of breath of one day
duration. The patient was in excellent health
until yesterday. She was awakened from her
sleep by sharp left sided chest pain. The pain
worsened with motion and deep breathing. The
pain has been progressively increasing in
severity and she now has severe left shoulder
pain. She complains of shortness of breath and
is very apprehensive about dying. She denies
any cough, fever, sputum production or
hemoptysis.
32. • She is married and had one normal delivery three
years ago. She is currently on birth control pills.
She has never been hospitalized except for labor
and delivery. Review of systems are negative. She
denies any past history of venous problems.
• She reveals having a similar transitory minor
episode of chest pain approximately one year ago
while she was in a vacation.
• She works as a computer programmer. She
smokes one pack of cigarettes a day for the past
eight years. She considers herself a social drinker.
33. ON PHYSICAL EXAMINATION
• BP=114/80 ; pulse 118 ; T= 37.0
• She appears to be in moderate respiratory
distress. She is well developed and nourished.
• Pertinent findings include a RR of 30 and
shallow breathing. There is dullness,
decreased chest expansion and decreased
breath sounds in the left base. There were no
rales or rubs.
34. CONT.
• Abdomen, pelvic and rectal exams are normal.
• The extremities reveal no evidence of edema,
cyanosis or clubbing.
• Patient has negative Homan's Sign.
• Joint exam revealed shoulder movements
complete in range. No warmth or tenderness
noted. The rest of the patient's joints are
normal.
35. FOLLOWING TESTS WERE DONE :
• ABG:
FI02 .21
pH 7.39
PCO2 30
HCO3 20
PaO2 80
SaO2 95%
No drop on Oxygen level
36. CXR reveals pleural effusion in the left base.
The left diaphragm is elevated.
Shoulder x-ray is normal.
There was a small amount of fluid in the left
pleural space.
TED = thromboembolic diseases
VTE = venous thromboembolism
DVT = deep vain thrombosis
PE =pulmonary embolisim
When any clot of the veins cuts its way through the right side of the heart and eventually it's pumped into the pulmonary arteries and the clot reaches to lungs
Symptoms : begin suddenly
(This can happen when person have to stay in bed after surgery or a serious illness, or when he sit for a long time on a flight or car trip.)
D-dimer levels are usually high in people with pulmonary embolism.
Westermark = cut off of pulmonary arteries bilaterally ( black arrows)
Fleishner’s sign = promenant central pulmonary artery ( red arrow )
Hamptons Hump = wedge-shaped plural based infeltrate that is occesionally seen in PE
Showing emboli (arrows) in segmental and sub segmental arteries in the right lower lobe
is an X-ray test that uses a special dye and camera to take pictures of the blood flow in the blood vessels of the lung" used only in rare cases to diagnose pulmonary embolism